2a) This educational activity is supported by grants from Bayer, Otsuka, & Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly Company. See archived programs, all by expert authors, still available for credit at https://t.co/jFwbLEcQSS.
— @CKD_ce (@ckd_ce) July 7, 2022
3) First, a poll. The IOM estimates how many Americans are harmed by errors involving prescription medications each year?
— @CKD_ce (@ckd_ce) July 7, 2022
5) Now that we know how frequent medications errors occur, how commonly is the class of #cardiovascular (#CV) drugs associated with medication errors compared to other reported drug classes?
— @CKD_ce (@ckd_ce) July 7, 2022
6b)https://t.co/9wIuCEAyVX andhttps://t.co/qfpDloGy47 by @cardiomet_ce faculty @johnfanikos pic.twitter.com/JEf8PvZ3U5
— @CKD_ce (@ckd_ce) July 7, 2022
8a) To illustrate how pharmacists can optimize the care of patients with #CVD, here’s a case: 61♂️ with #hypertension #dyslipidemia #diabetes, 20yr 🚬.
— @CKD_ce (@ckd_ce) July 7, 2022
VS: 148/94, HR 75
HDL 38, LDL 108, A1c 8.0%, eGFR 55
Meds lisinopril 10 qd, atorvastastin 20 qd, metformin 1000 bid
9) Meta-analyses on the role of the #pharmacist in #BP mgt ➡️improvement in SBP of 6 – 8 mmHg.
— @CKD_ce (@ckd_ce) July 7, 2022
🔓https://t.co/Gj55VzV8xP
🔓https://t.co/KHzZQgBnoz
Aside from med selection & titration, patient #adherence, #knowledge, & #QoL all improved w/ pharmacist care added to the CV team
11a) Speaking of community pharmacists – the #RxEACH study was a randomized trial that evaluated the effectiveness of community pharmacists' interventions on #CV risk: 🔓https://t.co/O6tgGzpN3k
— @CKD_ce (@ckd_ce) July 7, 2022
11c) Patients randomized to the pharmacist group received Medication Therapy Management (#MTM) consultation. Pharmacists assessed BP measurements, fasting lipids, A1c, GFR, etc. They also provided Rx recommendations (adding, titrating therapies)
— @CKD_ce (@ckd_ce) July 7, 2022
11e) There was a 2⃣1⃣% relative ⤵️ in #CV Risk (5.4% absolute risk reduction)! How did they do that? Specific improvements in:
— @CKD_ce (@ckd_ce) July 7, 2022
• LDL: – 7.7 mg/dL
• SBP – 9.37 mm Hg
• 20.2% difference in smoking cessation pic.twitter.com/7m5vQwLmyL
13) Pharmacists advise both patients and prescribing physicians in this regard! @Sglt2inhibitorL #SGLT2i @GoggleDocs @drricardocorrea @RpratleyMD @cpcannon @AmDiabetesAssn @goKDIGO @HannahBeba @claireyrivs @beaverspharmd
— @CKD_ce (@ckd_ce) July 7, 2022
15) Pharmacists caring for patients with #cardiometabolic risk are well trained and eager to participate in optimizing their care. Here’s the training pharmacists complete. Many maintain board certification and #multidisciplinary credentialing pic.twitter.com/W6ruaI2XRf
— @CKD_ce (@ckd_ce) July 7, 2022
17) So you made it! 🆓 CE/CME! #Physicians #pharmacists #nurses #NPs #PAs: go to https://t.co/bcmGV1Dp5W and claim your credit! I am @SnayCardsPharmD. Follow @ckd_ce (and @cardiomet_CE) for more tweetorials! #medtwittter #cardiotwitter #pharmacisttwitter #FOAMed
— @CKD_ce (@ckd_ce) July 7, 2022